We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$2.51B
AUM Growth
+$1.17B
Cap. Flow
+$1.14B
Cap. Flow %
45.4%
Top 10 Hldgs %
46.36%
Holding
1,466
New
813
Increased
130
Reduced
121
Closed
402

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$114M
2
IQ icon
iQIYI
IQ
+$19.6M
3
AER icon
AerCap
AER
+$18.3M
4
PEG icon
Public Service Enterprise Group
PEG
+$12.5M
5
HHH icon
Howard Hughes
HHH
+$12.3M

Sector Composition

Rank Sector Weight
1 Utilities 13.39%
2 Technology 9.99%
3 Consumer Discretionary 6.99%
4 Industrials 6.47%
5 Consumer Staples 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCP
376
DELISTED
GCP Applied Technologies Inc.
GCP
$654K 0.03%
+28,871
New +$779K
CBPO
377
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$654K 0.03%
+6,862
New +$646K
WBS
378
DELISTED
Webster Financial
WBS
$649K 0.03%
13,594
+241
+2% +$12K
BJRI icon
379
BJ's Restaurants
BJRI
$1.43B
$647K 0.03%
+14,726
New +$674K
IDXX icon
380
Idexx Laboratories
IDXX
$44.1B
$637K 0.03%
+2,312
New +$570K
AZPN
381
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$637K 0.03%
5,122
+743
+17% +$92.4K
HOLX
382
DELISTED
Hologic
HOLX
$635K 0.03%
+13,218
New +$611K
FLS icon
383
Flowserve
FLS
$10.2B
$634K 0.03%
+12,031
New +$591K
GBCI icon
384
Glacier Bancorp
GBCI
$6.09B
$629K 0.03%
+15,500
New +$636K
HQY icon
385
HealthEquity
HQY
$8.81B
$629K 0.03%
+9,620
New +$670K
FRC
386
DELISTED
First Republic Bank
FRC
$625K 0.02%
+6,400
New +$645K
SAGE
387
DELISTED
Sage Therapeutics
SAGE
$623K 0.02%
+3,402
New +$580K
PRKS icon
388
United Parks & Resorts
PRKS
$2.03B
$623K 0.02%
+20,099
New +$552K
DBI icon
389
Designer Brands
DBI
$298M
$622K 0.02%
+32,452
New +$663K
BLMN icon
390
Bloomin' Brands
BLMN
$980M
$621K 0.02%
+32,861
New +$642K
AXON
391
Axon Enterprise
AXON
$48.5B
$618K 0.02%
+9,624
New +$628K
AGO icon
392
Assured Guaranty
AGO
$3.26B
$614K 0.02%
+14,600
New +$644K
SF
393
Stifel
SF
$12.2B
$613K 0.02%
23,344
+14,380
+160% +$366K
PRK icon
394
Park National Corp
PRK
$3.67B
$606K 0.02%
+6,100
New +$592K
WBA
395
DELISTED
Walgreens Boots Alliance
WBA
$605K 0.02%
+11,068
New +$588K
CHMI
396
Cherry Hill Mortgage Investment Corp
CHMI
$108M
$603K 0.02%
+37,680
New +$639K
JAZZ icon
397
Jazz Pharmaceuticals
JAZZ
$16.5B
$600K 0.02%
+4,210
New +$566K
ATRI
398
DELISTED
Atrion Corp
ATRI
$599K 0.02%
+702
New +$620K
YELP icon
399
Yelp
YELP
$1.29B
$598K 0.02%
17,500
-18,529
-51% -$641K
ECOL
400
DELISTED
US Ecology, Inc.
ECOL
$595K 0.02%
+10,000
New +$590K

Similar funds

Michael Gelband's Q2 2019 Portfolio in Review

As of Q2 2019, Michael Gelband held 1,466 positions worth $2.51B, up 87% from $1.34B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Michael Gelband deployed $1.14B of net new capital in Q2 2019, opening 813 new positions and adding to 130 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 260,259 shares worth $76.3M.

By sector, the portfolio is most concentrated in Utilities at 13% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Altaba Inc, an estimated $114M trimmed.

  • Michael Gelband's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 260,259 shares worth $76.3M.
  • Michael Gelband added most to Aramark in Q2 2019, an estimated $58.3M increase.
  • Michael Gelband's biggest Q2 2019 reduction was Altaba Inc, cutting an estimated $114M.
  • Michael Gelband fully exited AerCap in Q2 2019, selling an estimated $18.3M.
  • Michael Gelband's ten largest holdings make up 46% of its $2.51B portfolio in Q2 2019.
  • Michael Gelband opened 813 new positions and closed 402 in Q2 2019.
  • Michael Gelband's portfolio value rose 87% quarter-over-quarter to $2.51B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.